Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 635,995
▲ 49% vs 2024
Profit
Growing€ 271,335
▲ 149% vs 2024
Debts
Low€ 6.9 million
▲ 36% vs 2024
DECURA PHARMA from Oostende, company number BE0817127010, closed financial year 2025 with a result of € 271,335 after tax. For that financial year DECURA PHARMA recorded a gross margin of € 635,995 and equity of € 3.8 million. Compared with financial year 2024, the result moved from € 108,814 to € 271,335. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.
What happened at DECURA PHARMA?
What happened at DECURA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New establishment in Gent. KBO
- New annual accounts for financial year 2025: profit of € 271,335 (▲ 149% vs 2024). Source: NBB ↗
- New establishment in Oostende. KBO
- Start of the company according to the CBE. KBO
- Ann Raes became a director. NBB
- Andy Decuypere became a director. NBB
In short
From € 283,336 profit in 2022 to € 271,335 profit in 2025.
Paid € 411,566 in corporate taxes since 2022.
Best year ever: 2022, with € 283,336 profit.
Paid out € 300,000 in dividends to the owners in total.
A new publication or filing at DECURA PHARMA? We notify you, reason included.
Follow DECURA PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind DECURA PHARMA are Ann Raes and Andy Decuypere. It owns 100% of Apotheek Raes, 100% of Health And Beauty Shop, 100% of Lindephar, 99.9% of Deraphar and 50% of Fidelmed itself.
Directors
According to the 2025 annual accounts
since 2009
since 2009
Establishments
Establishment units
Physical locations of this company
Gistelsesteenweg 18
8400 Oostende
Waalkens 11 box b
9030 Gent
Active since 1 June 2026
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0817.127.010
- VAT number
- BE 0817.127.010
- Registered office
- Gistelsesteenweg 18, 8400 Oostende
- Names & denominations
- DECURA PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 2009
- Peppol
- Active · Active since 2 Sept 2023
- Activities · NACE
Activiteiten van hoofdkantoren
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies